Joseph K. Han, MD, FARS, FAAAAI - Tackling CRSwNP Management With Emerging Biologic Therapies Targeting Epithelial Cytokines: Game On!

About this episode

The episode discusses the management of CRSwNP using emerging biologic therapies that target epithelial cytokines.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZYK865. CME/MOC/CC/AAPA credit will be available until December 15, 2026. Tackling CRSwNP Management With Emerging Biologic Therapies Targeting Epithelial Cytokines: Game On! In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals. Disclosure information is available at the beginning of the video presentation.

People in this episode

Guest: Joseph K. Han, MD, FARS, FAAAAI

Topics covered

• CRSwNP management
• biologic therapies
• epithelial cytokines
• healthcare education
• patient care

Keywords

• CRSwNP
• biologic therapies
• epithelial cytokines
• healthcare professionals
• continuing education

Sponsors

AstraZeneca Pharmaceuticals

Mentioned in this episode

Organizations: PeerView Institute for Medical Education, Accreditation Council for Continuing Medical Education, Accreditation Council for Pharmacy Education, American Nurses Credentialing Center

More episodes of PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast

• Adam Friedman, MD, FAAD - Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to Resolution · May 29, 2026 · 55 min
• Bhavana Pothuri, MD, MS / Premal Thaker, MD, MS - Targeting With Precision in Advanced Ovarian Cancer: Integrating Approved and Novel Agents Into Personalized Treatment Plans · May 29, 2026 · 51 min
• Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH, Richard Dang, PharmD - RSV in Focus: Pharmacists Driving Vaccine Access, Confidence, and Education · May 7, 2026 · 60 min
• April W. Armstrong, MD, MPH - A New Era in Psoriasis Care With Oral IL-23 Inhibitors · May 7, 2026 · 34 min
• Guy Young, MD - Driving Innovation Forward in Hemophilia B With Gene Therapy: Clinical Conversations on Progress and Guidance on Practical Delivery · April 27, 2026 · 53 min
• Haydar Frangoul, MD, MS, Akshay Sharma, MBBS, MSc - Transformative Care for Hemoglobinopathies: Guidance on the Gene Therapy Experience in SCD and Thalassemia · April 15, 2026 · 52 min